Bio Rad Stock Target Price and Analyst Consensus
BIO Stock | USD 345.87 3.69 1.06% |
The current analyst and expert consensus on Bio Rad is Strong Buy, with 5 strong buy opinions. The current projected Bio Rad target price consensus is 523.6 with 6 analyst opinions. The most common way Bio-Rad Laboratories analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Bio Rad executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Bio Rad. We strongly encourage you to use your own analysis of Bio-Rad Laboratories to validate this buy or sell advice. Bio Rad buy-or-sell recommendation module provides average expert sentiment on the projected Bio-Rad Laboratories target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Bio Rad to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 476.48 | Highest Forecast 581.2 | Target Price 523.6 |
Bio |
It's important to approach Bio Rad's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Bio Rad Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bio target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Bio Rad's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
6 | Strong Buy |
Most Bio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Bio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Bio-Rad Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationBio Rad Target Price Projection
Bio Rad's current and average target prices are 345.87 and 523.60, respectively. The current price of Bio Rad is the price at which Bio Rad Laboratories is currently trading. On the other hand, Bio Rad's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Bio Rad Market Quote on 28th of March 2024
Target Price
Analyst Consensus On Bio Rad Target Price
Bio Rad Analyst Ratings
Bio Rad's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Bio Rad stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Bio Rad's financials, market performance, and future outlook by experienced professionals. Bio Rad's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Bio Rad price targets
Bio Rad's stock target price is an estimate of its future price, usually made by analysts. Using Bio Rad's target price to determine if it is a suitable investment can be done through the following steps:- Look at Bio Rad's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bio Rad's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Bio Rad Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bio Rad is a key component of Bio Rad valuation and have some predictive power on the future returns of a Bio Rad.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Rad's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Cash Cows Invested few shares | ||
Investor Favorites Invested a lot of shares | ||
Macroaxis Picks Invested over 100 shares | ||
Warren Buffett Holdings Invested few shares | ||
Momentum Invested over 40 shares | ||
ESG Investing Invested few shares | ||
Artificial Intelligence Invested few shares | ||
Machinery Invested over 100 shares | ||
Dividend Beast Invested over 70 shares | ||
Millennials Best Invested over 30 shares | ||
Tech Growth Invested a lot of shares | ||
Driverless Cars Invested over 50 shares | ||
Disruptive Technologies Invested few shares | ||
Information Technology ETFs Invested few shares |
Check out Macroaxis Advice on Bio Rad to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
The data published in Bio Rad's official financial statements usually reflect Bio Rad's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bio-Rad Laboratories. For example, before you start analyzing numbers published by Bio accountants, it's critical to develop an understanding of what Bio Rad's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Bio Rad's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Rad's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bio Rad's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bio Rad Laboratories. Please utilize our Beneish M Score to check the likelihood of Bio Rad's management manipulating its earnings.